Skip to Main Content

Paper Details

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
J Clin Oncol
754
2018
Author NameAffiliation
Janet A DunnWarwick Clinical Trials Unit, University of Warwick Oliver Chapman and Christopher J. Poole, University Hospitals Coventry and Warwickshire Charles Hutchinson and Jeremy Dale, Warwick Medical School, University of Warwick, Heart of England National Health Service Foundation Trust, Queen Mary University of London Ajay Kakkar, Thrombosis Research Institute, University of Oxford, Hull York Medical School, Fred Hutchinson Cancer Research Center, McMaster University
Mark N LevineWarwick Clinical Trials Unit, University of Warwick Oliver Chapman and Christopher J. Poole, University Hospitals Coventry and Warwickshire Charles Hutchinson and Jeremy Dale, Warwick Medical School, University of Warwick, Heart of England National Health Service Foundation Trust, Queen Mary University of London Ajay Kakkar, Thrombosis Research Institute, University of Oxford, Hull York Medical School, Fred Hutchinson Cancer Research Center, McMaster University
  • 1 - 2

Datasets